- Title
- Physiological mechanisms of unexplained (functional) gastrointestinal disorders
- Creator
- Burns, Grace L.; Hoedt, Emily C.; Walker, Marjorie M.; Talley, Nicholas J.; Keely, Simon
- Relation
- Journal of Physiology Vol. 599, Issue 23, p. 5141-5161
- Publisher Link
- http://dx.doi.org/10.1113/JP281620
- Publisher
- Wiley-Blackwell
- Resource Type
- journal article
- Date
- 2021
- Description
- Functional gastrointestinal disorders (FGIDs) encompass a range of complex conditions with similar clinical characteristics and no overt pathology. Recent recognition of sub-clinical pathologies in FGIDs, in conjunction with physiological and biochemical abnormalities including increased intestinal permeability, microbial profile alterations, differences in metabolites and extra-intestinal manifestations of disease, call into question the designation of these conditions as ‘functional’. This is despite significant heterogeneity in both symptom profile and specifics of reported physiological abnormalities hampering efforts to determine defined mechanisms that drive onset and chronicity of symptoms. Instead, the literature demonstrates these conditions are disorders of homeostatic imbalance, with disruptions in both host and microbial function and metabolism. This imbalance is also associated with extraintestinal abnormalities including psychological comorbidities and fatigue that may be a consequence of gastrointestinal disruption. Given the exploitation of such abnormalities will be crucial for improved therapeutic selection, an enhanced understanding of the relationship between alterations in function of the gastrointestinal tract and the response of the immune system is of interest in identifying mechanisms that drive FGID onset and chronicity. Considerations for future research should include the role of sex hormones in regulating physiological functions and treatment responses in patients, as well as the importance of high-level phenotyping of clinical, immune, microbial and physiological parameters in study cohorts. There is opportunity to examine the functional contribution of the microbiota and associated metabolites as a source of mechanistic insight and targets for therapeutic modulation.
- Subject
- biological mechanisms; functional dyspepsia; irritable bowel syndrome; physiology
- Identifier
- http://hdl.handle.net/1959.13/1450872
- Identifier
- uon:44040
- Identifier
- ISSN:0022-3751
- Language
- eng
- Reviewed
- Hits: 339
- Visitors: 339
- Downloads: 0